Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.1M Sell
58,300
-17,800
-23% -$14.7M 0.03% 721
2026
Q1
$55.6M Buy
76,100
+600
+0.8% +$470K 0.03% 612
2025
Q4
$63.5M Buy
75,500
+600
+0.8% +$514K 0.03% 595
2025
Q3
$55.2M Buy
74,900
+13,100
+21% +$8.64M 0.03% 606
2025
Q2
$34.1M Buy
61,800
+5,400
+10% +$3.13M 0.02% 748
2025
Q1
$33.4M Buy
56,400
+19,400
+52% +$12.2M 0.03% 657
2024
Q4
$22.8M Buy
37,000
+29,900
+421% +$17.5M 0.02% 960
2024
Q3
$3.85M Hold
7,100
﹤0.01% 2159
2024
Q2
$3.05M Hold
7,100
﹤0.01% 2249
2024
Q1
$2.8M Hold
7,100
﹤0.01% 2361
2023
Q4
$2.7M Buy
7,100
+4,900
+223% +$2.28M ﹤0.01% 2436
2023
Q3
$1.08M Buy
+2,200
New +$1.08M ﹤0.01% 3009

Other funds holding ARGX

David Shaw's ARGX Position: Q2 2026 in Review

David Shaw reduced its argenx (ARGX) stake by 84% in Q2 2026, selling an estimated $36.2M and leaving 8,263 shares worth $7.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

David Shaw first reported a position in ARGX in Q2 2018 and has held it in 25 quarters since. The position peaked at $177M in Q4 2024. 505 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • David Shaw held 8,263 shares of argenx worth $7.67M as of Q2 2026.
  • David Shaw sold 43,859 argenx shares in Q2 2026, an estimated $36.2M.
  • argenx made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2051 holding.
  • David Shaw first reported a position in argenx in Q2 2018 and has held it in 25 quarters since.
  • David Shaw's argenx position peaked at $177M in Q4 2024.
  • 505 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.